Select therapeutic use:
Indications for CETROTIDE:
Inhibition of premature LH surges in women undergoing controlled ovarian stimulation for in vitro fertilization.
Give by SC inj into lower abdominal wall during early to mid-follicular phase; see literature. 3mg once on stimulation day 7, or 0.25mg daily beginning on stimulation day 5 or 6 and continuing until day of hCG administration.
Pregnancy (Cat.X). Nursing mothers.
Do complete gynecological and endocrinological exam first.
Ovarian hyperstimulation syndrome, nausea, headache, inj site reactions, elevated enzymes (eg, ALT, alkaline phosphatase).
Vials 0.25mg (w. diluent)—1
3mg (w. diluent)—1